K
kelman13
We package our hemostatic powder in laminate tubes. We then send those tubes off to be sterilized.
We test the tube seals by submerging them in water and pulling vacuum. Bubbling from the tubes indicated leaks. What is the ACL for our tubes?
We have been told by our FDA consultant that because the products are sterile that the AQL is 0.0000. Zero defects.
-------- more info:
lot of 150k produced sterilize
QC indicated leaks
We then did a dry vac procedure and removed any tubes that were crushed after removing from vacuum = leaker. (validated prior to testing)
~47 boxes
Then QC retested and found 1 tube that had a small leak.
QA used the ANSI table on a per box basis, and then applied that heightened level of testing across the entire batch.
We had 1 leaking tube out of ~3700 tested. (<0.03 AQL)
Based on the guidance from our FDA consultant we are rejecting the lot.
Risk: If this lot was not sterilized (all 150k) & distributed there was be ZERO infections resulting from the normal use of the product. Nothing grows in the product.
If there was chance of causing serious injury as a result of the 0.03AQL I would be concerned, but there isn't.
On top of that in an MDD article online there is this line: The agency determined an AQL of 0.25% for invasive devices and an AQL of 0.65% for noninvasive devices.
How can our product be held to a higher AQC standard than invasive devices in the industry? (article is from 2004)
Thx for insight
We test the tube seals by submerging them in water and pulling vacuum. Bubbling from the tubes indicated leaks. What is the ACL for our tubes?
We have been told by our FDA consultant that because the products are sterile that the AQL is 0.0000. Zero defects.
-------- more info:
lot of 150k produced sterilize
QC indicated leaks
We then did a dry vac procedure and removed any tubes that were crushed after removing from vacuum = leaker. (validated prior to testing)
~47 boxes
Then QC retested and found 1 tube that had a small leak.
QA used the ANSI table on a per box basis, and then applied that heightened level of testing across the entire batch.
We had 1 leaking tube out of ~3700 tested. (<0.03 AQL)
Based on the guidance from our FDA consultant we are rejecting the lot.
Risk: If this lot was not sterilized (all 150k) & distributed there was be ZERO infections resulting from the normal use of the product. Nothing grows in the product.
If there was chance of causing serious injury as a result of the 0.03AQL I would be concerned, but there isn't.
On top of that in an MDD article online there is this line: The agency determined an AQL of 0.25% for invasive devices and an AQL of 0.65% for noninvasive devices.
How can our product be held to a higher AQC standard than invasive devices in the industry? (article is from 2004)
Thx for insight